{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:54:58Z","timestamp":1783486498637,"version":"3.55.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.beem.2017.04.004","type":"journal-article","created":{"date-parts":[[2017,4,14]],"date-time":"2017-04-14T22:16:20Z","timestamp":1492208180000},"page":"161-173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Hypothyroidism associated with parathyroid disorders"],"prefix":"10.1016","volume":"31","author":[{"given":"Giovanna","family":"Mantovani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca Marta","family":"Elli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Corbetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.beem.2017.04.004_bib1","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1210\/jc.2015-3908","article-title":"Epidemiology and diagnosis of hypoparathyroidism","volume":"101","author":"Clarke","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.04.004_bib2","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1530\/JME-16-0124","article-title":"Disorders of the calcium-sensing receptor and partner proteins: insight into the molecular basis of calcium homeostasis","volume":"57","author":"Hannan","year":"2016","journal-title":"J\u00a0Mol Endocrinol"},{"key":"10.1016\/j.beem.2017.04.004_bib3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ecl.2010.02.004","article-title":"Genetic disorders and defects in vitamin D action","volume":"39","author":"Malloy","year":"2010","journal-title":"Endocrinol Metab Clin N Am"},{"key":"10.1016\/j.beem.2017.04.004_bib4","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/MNH.0b013e328304651c","article-title":"The development of the parathyroid gland: from fish to human","volume":"17","author":"Zajac","year":"2008","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.beem.2017.04.004_bib5","series-title":"Surgery of the thyroid and parathyroid glands","first-page":"12","article-title":"Applied embryology of the thyroid and parathyroid glands","author":"Henry","year":"2003"},{"key":"10.1016\/j.beem.2017.04.004_bib6","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1172\/JCI42021","article-title":"Gata-3-deficient mice develop parathyroid abnormalities due to dysregulation of the parathyroid-specific transcription factor Gcm2","volume":"120","author":"Grigorieva","year":"2010","journal-title":"J\u00a0Clin Investig"},{"key":"10.1016\/j.beem.2017.04.004_bib7","series-title":"Molecular biology of the parathyroid","first-page":"1","article-title":"Development of parathyroid glands","author":"G\u00fcnther","year":"2005"},{"key":"10.1016\/j.beem.2017.04.004_bib8","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.ydbio.2007.02.014","article-title":"Gcm2 is required for the differentiation and survival of parathyroid precursor cells in the parathyroid\/thymus primordial","volume":"305","author":"Liu","year":"2007","journal-title":"Dev Biol"},{"key":"10.1016\/j.beem.2017.04.004_bib9","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/350473a0","article-title":"Regionally restricted developmental defects resulting from targeted disruption of the mouse homeobox gene hox-1.5","volume":"350","author":"Chisaka","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.beem.2017.04.004_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00441-013-1649-z","article-title":"Hes1 is required for the development of pharyngeal organs and survival of neural crest-derived mesenchymal cells in pharyngeal arches","volume":"353","author":"Kameda","year":"2013","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.beem.2017.04.004_bib11","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1242\/dev.121.7.1989","article-title":"The role of Hoxa-3 in mouse thymus and thyroid development","volume":"121","author":"Manley","year":"1995","journal-title":"Development"},{"key":"10.1016\/j.beem.2017.04.004_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/dbio.1997.8827","article-title":"Hox group 3 paralogs regulate the development and migration of the thymus, thyroid, and parathyroid glands","volume":"195","author":"Manley","year":"1998","journal-title":"Dev Biol"},{"key":"10.1016\/j.beem.2017.04.004_bib13","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1471-2172-3-12","article-title":"Stage-specific changes in fetal thymocyte proliferation during the CD4-8- to CD4+8+ transition in wild type, Rag1-\/-, and Hoxa3,Pax1 mutant mice","volume":"3","author":"Su","year":"2002","journal-title":"BMC Immunol"},{"key":"10.1016\/j.beem.2017.04.004_bib14","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1006\/dbio.1995.1047","article-title":"Undulated phenotypes suggest a role of Pax-1 for the development of vertebral and extravertebral structures","volume":"167","author":"Dietrich","year":"1995","journal-title":"Dev Biol"},{"key":"10.1016\/j.beem.2017.04.004_bib15","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1006\/dbio.1995.1248","article-title":"Characterization and developmental expression of Pax9, a paired-box-containing gene related Pax1","volume":"170","author":"Neub\u00fcser","year":"1995","journal-title":"Dev Biol"},{"key":"10.1016\/j.beem.2017.04.004_bib16","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1101\/gad.12.17.2735","article-title":"Pax9-deficient mice lack pharyngeal pouch derivatives and teeth and exhibit craniofacial and limb abnormalities","volume":"12","author":"Peters","year":"1998","journal-title":"Genes Dev"},{"key":"10.1016\/j.beem.2017.04.004_bib17","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1006\/dbio.2001.0342","article-title":"Hoxa3 and Pax1 regulate epithelial cell death and proliferation during thymus and parathyroid organogenesis","volume":"236","author":"Su","year":"2001","journal-title":"Dev Biol"},{"key":"10.1016\/j.beem.2017.04.004_bib18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1242\/dev.122.1.23","article-title":"Pax1 is expressed during development of the thymus epithelium and is required for normal T-cell maturation","volume":"122","author":"Wallin","year":"1996","journal-title":"Development"},{"key":"10.1016\/j.beem.2017.04.004_bib19","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1242\/dev.129.13.3033","article-title":"Eya1 is required for the morphogenesis of mammalian thymus, parathyroid and thyroid","volume":"129","author":"Xu","year":"2002","journal-title":"Development"},{"key":"10.1016\/j.beem.2017.04.004_bib20","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ydbio.2005.12.015","article-title":"Patterning of the third pharyngeal pouch into thymus\/parathyroid by Six and Eya1","volume":"293","author":"Zou","year":"2006","journal-title":"Dev Biol"},{"key":"10.1016\/j.beem.2017.04.004_bib21","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-15-0628","article-title":"European Society of Endocrinology clinical guideline: treatment of chronic hypoparathyroidism in adults","volume":"173","author":"Bollerslev","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.04.004_bib22","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1210\/jc.2015-3907","article-title":"Management of hypoparathyroidism: summary statement and guidelines","volume":"101","author":"Brandi","year":"2016","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.04.004_bib23","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/jbmr.2501","article-title":"The epidemiology of non-surgical hypoparathyroidism in Denmark: a nationwide case finding study","volume":"30","author":"Underbjerg","year":"2015","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2017.04.004_bib24","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1002\/jbmr.2004","article-title":"Prevalence and incidence of hypoparathyroidism in the United States using a large claims database","volume":"28","author":"Powers","year":"2013","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2017.04.004_bib25","doi-asserted-by":"crossref","first-page":"E2421","DOI":"10.1210\/jc.2014-2174","article-title":"Comprehensive next-generation sequencing analyses of hypoparathyroidism: identification of novel GCM2 mutations","volume":"99","author":"Mitsui","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.04.004_bib26","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00431-013-1964-0","article-title":"Defining new guidelines for screening the 22q11.2 deletion based on a clinical and dysmorphologic evaluation of 194 individuals and review of the literature","volume":"172","author":"Monteiro","year":"2013","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.beem.2017.04.004_bib27","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/gim.2014.175","article-title":"Practical guidelines for managing adults with 22q11.2 deletion syndrome","volume":"17","author":"Fung","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/j.beem.2017.04.004_bib28","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1002\/ajmg.1320520415","article-title":"Hypoparathyroidism as the major manifestation in two patients with 22q11 deletions","volume":"52","author":"Scire","year":"1994","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.beem.2017.04.004_bib29","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1001\/archpedi.1997.02170440107021","article-title":"Velo-cardiofacial syndrome presenting as hypocalcemia in early adolescence","volume":"151","author":"Sykes","year":"1997","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.beem.2017.04.004_bib30","first-page":"852","article-title":"Adult onset hypoparathyroidism in a patient with psychiatric illness: a 71 years delayed diagnosis of DiGeorge syndrome","volume":"33","author":"Passeri","year":"2010","journal-title":"J\u00a0Endocrinol Investig"},{"key":"10.1016\/j.beem.2017.04.004_bib31","doi-asserted-by":"crossref","first-page":"E1115","DOI":"10.1210\/jc.2011-0057","article-title":"Increased risk for non-autoimmune hypogonadism in young patients with congenital heart defects","volume":"96","author":"Passeri","year":"2011","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.04.004_bib32","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.autrev.2014.01.044","article-title":"Diagnosis and classification of autoimmune parathyroid disease","volume":"13","author":"Betterle","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.beem.2017.04.004_bib33","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1210\/jc.2011-2461","article-title":"Autoimmune polyendocrine syndrome type 1: an extensive longitudinal study in Sardinian patients","volume":"97","author":"Meloni","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.04.004_bib34","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nri.2016.9","article-title":"AIRE expands: new roles in immune tolerance and beyond","volume":"16","author":"Anderson","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.beem.2017.04.004_bib35","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa0706487","article-title":"Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen","volume":"358","author":"Alimohammadi","year":"2008","journal-title":"N.\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2017.04.004_bib36","first-page":"20","article-title":"A\u00a0series of cases of splenomegaly in children with anemia and peculiar bone changes","volume":"37","author":"Cooley","year":"1925","journal-title":"Trans Am Pediatr Soc"},{"key":"10.1016\/j.beem.2017.04.004_bib37","series-title":"The molecular basis of blood diseases","first-page":"157","article-title":"The thalassemias","author":"Weatherall","year":"1994"},{"key":"10.1016\/j.beem.2017.04.004_bib38","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ajh.2830120113","article-title":"Thalassemia: recent insights into molecular mechanisms","volume":"12","author":"Steinberg","year":"1982","journal-title":"Am J Hematol"},{"key":"10.1016\/j.beem.2017.04.004_bib39","doi-asserted-by":"crossref","first-page":"7470","DOI":"10.1073\/pnas.86.19.7470","article-title":"Gamma-delta-beta-thalassemia due to a de novo mutation deleting the 5-prime beta-globin gene activation-region hypersensitive sites","volume":"86","author":"Driscoll","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.beem.2017.04.004_bib40","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/adc.70.1.30","article-title":"Effect of alpha thalassaemia trait and enhanced gamma chain production on disease severity in beta thalassaemia major and intermedia","volume":"70","author":"Gringras","year":"1994","journal-title":"Arch Dis Child"},{"issue":"9","key":"10.1016\/j.beem.2017.04.004_bib41","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/BF03343916","article-title":"Endocrine complications of thalassemia","volume":"24","author":"Tiosano","year":"2001","journal-title":"J\u00a0Endocrinol Investig"},{"key":"10.1016\/j.beem.2017.04.004_bib42","doi-asserted-by":"crossref","first-page":"813098","DOI":"10.1155\/2015\/813098","article-title":"Endocrine and bone complications in \u03b2-thalassemia intermedia: current understanding and treatment","volume":"2015","author":"Inati","year":"2015","journal-title":"Biomed Res Int"},{"issue":"2","key":"10.1016\/j.beem.2017.04.004_bib43","first-page":"642","article-title":"Endocrine complications in patients with thalassemia major","volume":"5","author":"Toumba","year":"2007","journal-title":"Pediatr Endocrinol Rev"},{"issue":"5","key":"10.1016\/j.beem.2017.04.004_bib44","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3324\/haematol.10842","article-title":"Liver iron concentrations and urinary hepcidin in beta-thalassemia","volume":"92","author":"Origa","year":"2007","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.beem.2017.04.004_bib45","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1007\/s00277-012-1412-7","article-title":"Serum ferritin levels and endocrinopathy in medically treated patients with b thalassemia major","volume":"91","author":"Belhoul","year":"2012","journal-title":"Ann Hematol"},{"key":"10.1016\/j.beem.2017.04.004_bib46","doi-asserted-by":"crossref","first-page":"4021","DOI":"10.1182\/blood-2009-06-225615","article-title":"Pancreatic iron loading predicts cardiac iron loading in thalassemia major","volume":"114","author":"Noetzli","year":"2009","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.beem.2017.04.004_bib47","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/ajh.22247","article-title":"Pituitary iron and volume predict hypogonadism in transfusional iron overload","volume":"87","author":"Noetzli","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.beem.2017.04.004_bib48","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1111\/j.1365-2141.2009.07970.x","article-title":"Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassaemia major","volume":"148","author":"Farmaki","year":"2010","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.beem.2017.04.004_bib49","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM200102153440707","article-title":"Thyroid hormone and the cardiovascular system","volume":"344","author":"Klein","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2017.04.004_bib50","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1750-1172-5-11","article-title":"Beta-thalassemia","volume":"5","author":"Galanello","year":"2010","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"10.1016\/j.beem.2017.04.004_bib51","doi-asserted-by":"crossref","first-page":"728","DOI":"10.3892\/br.2016.646","article-title":"Impact of genotype on endocrinal complications in \u03b2-thalassemia patients","volume":"4","author":"Al-Akhras","year":"2016","journal-title":"Biomed Rep"},{"key":"10.1016\/j.beem.2017.04.004_bib52","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3389\/fphys.2016.00458","article-title":"Autosomal dominant hypocalcemia (hypoparathyroidism) types 1 and 2","volume":"7","author":"Roszko","year":"2016","journal-title":"Front Physiol"},{"key":"10.1016\/j.beem.2017.04.004_bib53","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/ng1012","article-title":"HRD\/Autosomal Recessive Kenny-Caffey Syndrome Consortium. Mutation of TBCE causes hypoparathyroidism-retardation-dysmorphism and autosomal recessive Kenny-Caffey syndrome","volume":"32","author":"Parvari","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.beem.2017.04.004_bib54","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/jbmr.2091","article-title":"A\u00a0recurrent de novo FAM111A mutation causes Kenny-Caffey syndrome type 2","volume":"29","author":"Isojima","year":"2014","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2017.04.004_bib55","first-page":"922","article-title":"Pseudohypoparathyroidism: an example of \u201cSeabright-Bantam syndrome\u201d","volume":"30","author":"Albright","year":"1942","journal-title":"Endocrinology"},{"issue":"5","key":"10.1016\/j.beem.2017.04.004_bib56","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1073\/pnas.78.5.3098","article-title":"Pseudohypoparathyroidism: inheritance of deficient receptor-cyclase coupling activity","volume":"78","author":"Farfel","year":"1981","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"20","key":"10.1016\/j.beem.2017.04.004_bib57","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJM199005173222002","article-title":"Mutation in the gene encoding the stimulatory G protein of adenylate cyclase in Albright's hereditary osteodystrophy","volume":"322","author":"Patten","year":"1990","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.beem.2017.04.004_bib58","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/nrendo.2016.52","article-title":"Pseudohypoparathyroidism and Gs\u03b1-cAMP-linked disorders: current view and open issues","volume":"12","author":"Mantovani","year":"2016","journal-title":"Nat Rev Endocrinol"},{"issue":"2","key":"10.1016\/j.beem.2017.04.004_bib59","first-page":"65","article-title":"GNAS locus and pseudohypoparathyroidism","volume":"63","author":"Bastepe","year":"2005","journal-title":"Horm Res"},{"issue":"2","key":"10.1016\/j.beem.2017.04.004_bib60","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJMoa011262","article-title":"Paternally inherited inactivating mutations of the GNAS1 gene in progressive osseous heteroplasia","volume":"346","author":"Shore","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"23","key":"10.1016\/j.beem.2017.04.004_bib61","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1056\/NEJMoa1012717","article-title":"Recurrent PRKAR1A mutation in acrodysostosis with hormone resistance","volume":"364","author":"Linglart","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.beem.2017.04.004_bib62","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.ajhg.2012.03.004","article-title":"Exome sequencing identifies PDE4D mutations in acrodysostosis","volume":"90","author":"Lee","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.beem.2017.04.004_bib63","first-page":"675","article-title":"Endocrine manifestations of stimulatory G protein \u03b1-subunit mutations and the role of genomic imprinting","volume":"22","author":"Weinstein","year":"2001","journal-title":"Endocr Rev"},{"key":"10.1016\/j.beem.2017.04.004_bib64","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1210\/jc.2003-030393","article-title":"The stimulatory G protein \u03b1 subunit is imprinted in human thyroid glands: implications for thyroid function in pseudohypoparathyroidism type 1A and 1B","volume":"88","author":"Liu","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.04.004_bib65","doi-asserted-by":"crossref","first-page":"3738","DOI":"10.1210\/jc.2007-0869","article-title":"Genetic analysis and evaluation of resistance to thyrotropin and growth hormone-releasing hormone in pseudohypoparathyroidism type Ib","volume":"92","author":"Mantovani","year":"2007","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.04.004_bib66","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI10431","article-title":"A\u00a0GNAS imprinting defect in pseudohypoparathyroidism type Ib","volume":"106","author":"Liu","year":"2000","journal-title":"J\u00a0Clin Investig"},{"issue":"8","key":"10.1016\/j.beem.2017.04.004_bib67","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1172\/JCI19159","article-title":"Autosomal dominant pseudohypoparathyroidism type Ib is associated with a heterozygous microdeletion that likely disrupts a putative imprinting control element of GNAS","volume":"112","author":"Bastepe","year":"2003","journal-title":"J\u00a0Clin Investig"},{"issue":"1","key":"10.1016\/j.beem.2017.04.004_bib68","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng1487","article-title":"Deletion of the NESP55 differentially methylated region causes loss of maternal GNAS imprints and pseudohypoparathyroidism type Ib","volume":"37","author":"Bastepe","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/j.beem.2017.04.004_bib69","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1086\/429932","article-title":"A\u00a0novel STX16 deletion in autosomal dominant pseudohypoparathyroidism type Ib redefines the boundaries of a cis-acting imprinting control element of GNAS","volume":"76","author":"Linglart","year":"2005","journal-title":"Am J Hum Genet"},{"issue":"5","key":"10.1016\/j.beem.2017.04.004_bib70","doi-asserted-by":"crossref","first-page":"E863","DOI":"10.1210\/jc.2011-2804","article-title":"A\u00a0new deletion ablating NESP55 causes loss of maternal imprint of A\/B GNAS and autosomal dominant pseudohypoparathyroidism type Ib","volume":"97","author":"Richard","year":"2012","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"4","key":"10.1016\/j.beem.2017.04.004_bib71","doi-asserted-by":"crossref","first-page":"E724","DOI":"10.1210\/jc.2013-3704","article-title":"Autosomal dominant pseudohypoparathyroidism type Ib: a novel inherited deletion ablating STX16 causes loss of imprinting at the A\/B DMR","volume":"99","author":"Elli","year":"2014","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"5","key":"10.1016\/j.beem.2017.04.004_bib72","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/8756-3282(93)90204-N","article-title":"The renal response to exogenous parathyroid hormone in treated pseudohypoparathyroidism","volume":"14","author":"Stone","year":"1993","journal-title":"Bone"},{"key":"10.1016\/j.beem.2017.04.004_bib73","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/0002-9343(80)90270-3","article-title":"Skeletal responsiveness in pseudohypoparathyroidism: a spectrum of clinical disease","volume":"68","author":"Kidd","year":"1980","journal-title":"Am J Med"},{"key":"10.1016\/j.beem.2017.04.004_bib74","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/jbmr.5650080111","article-title":"Pseudohypoparathyroidism with osteitis fibrosa cystica: direct demonstration of skeletal responsiveness to parathyroid hormone in cells cultured from bone","volume":"8","author":"Murray","year":"1993","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2017.04.004_bib75","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1001\/archsurg.133.6.673","article-title":"Osteitis fibrosa cystica with renal parathyroid hormone resistance: a review of pseudohypoparathyroidism with insight into calcium homeostasis","volume":"133","author":"Eubanks","year":"1998","journal-title":"Arch Surg"},{"key":"10.1016\/j.beem.2017.04.004_bib76","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1210\/jcem-22-1-59","article-title":"Pseudohypoparathyroidism with secondary hyperparathyroidism and osteitis fibrosa","volume":"22","author":"Kolb","year":"1962","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.04.004_bib77","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1359\/jbmr.2000.15.7.1412","article-title":"Serial changes in bone mineral density and bone turnover after correction of secondary hyperparathyroidism in a patient with pseudohypoparathyroidism type Ib","volume":"15","author":"Tollin","year":"2000","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2017.04.004_bib78","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/jbmr.5650110103","article-title":"Normal parathyroid hormone responsiveness of bone-derived cells from a patient with pseudohypoparathyroidism","volume":"11","author":"Ish-Shalom","year":"1996","journal-title":"J\u00a0Bone Miner Res"},{"key":"10.1016\/j.beem.2017.04.004_bib79","doi-asserted-by":"crossref","first-page":"4070","DOI":"10.1210\/jc.2002-022028","article-title":"Growth hormone-releasing hormone resistance in pseudohypoparathyroidism type Ia: new evidence for imprinting of the Gs\u03b1 gene","volume":"88","author":"Mantovani","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.04.004_bib80","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1210\/jc.2003-030028","article-title":"Growth hormone deficiency in pseudohypoparathyroidism type 1a: another manifestation of multihormone resistance","volume":"88","author":"Germain-Lee","year":"2003","journal-title":"J\u00a0Clin Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.04.004_bib81","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/BF03347406","article-title":"GH secretion in a cohort of children with pseudohypoparathyroidism type Ia","volume":"30","author":"de Sanctis","year":"2007","journal-title":"J\u00a0Endocrinol Investig"},{"key":"10.1016\/j.beem.2017.04.004_bib82","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0022-3476(85)80189-X","article-title":"Infantile hypothyroidism in two sibs: an unusual presentation of pseudohypoparathyroidism type Ia","volume":"107","author":"Levine","year":"1985","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.beem.2017.04.004_bib83","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1530\/eje.0.1480463","article-title":"A\u00a0new heterozygous mutation (L338N) in the human Gs\u03b1 (GNAS1) gene as a cause for congenital hypothyroidism in Albright's hereditary osteodystrophy","volume":"148","author":"Pohlenz","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.beem.2017.04.004_bib84","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1515\/JPEM.2006.19.8.1049","article-title":"Pseudohypoparathyroidism type 1a with congenital hypothyroidism","volume":"19","author":"Pinsker","year":"2006","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"issue":"Suppl. 2","key":"10.1016\/j.beem.2017.04.004_bib85","first-page":"663","article-title":"Resistance to growth hormone releasing hormone and gonadotropins in Albright's hereditary osteodystrophy","volume":"19","author":"Mantovani","year":"2006","journal-title":"J\u00a0Pediatr Endocrinol Metab"},{"key":"10.1016\/j.beem.2017.04.004_bib86","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1242\/dev.110833","article-title":"Multiple roles for HOXA3 in regulating thymus and parathyroid differentiation and morphogenesis in mouse","volume":"141","author":"Chojnowski","year":"2014","journal-title":"Development"},{"key":"10.1016\/j.beem.2017.04.004_bib87","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1002\/(SICI)1097-0177(199608)206:4<379::AID-AJA4>3.0.CO;2-F","article-title":"Expression of the T-box family genes, Tbx1-Tbx5, during early mouse development","volume":"206","author":"Chapman","year":"1996","journal-title":"Dev Dyn"},{"key":"10.1016\/j.beem.2017.04.004_bib88","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1172\/JCI24156","article-title":"An interstitial deletion-insertion involving chromosomes 2p25.3 and Xq27.1, near SOX3, causes X-linked recessive hypoparathyroidism","volume":"115","author":"Bowl","year":"2005","journal-title":"J\u00a0Clin Investig"}],"container-title":["Best Practice &amp; Research Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X17300325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521690X17300325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:52:27Z","timestamp":1761497547000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521690X17300325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":88,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S1521690X17300325"],"URL":"https:\/\/doi.org\/10.1016\/j.beem.2017.04.004","relation":{},"ISSN":["1521-690X"],"issn-type":[{"value":"1521-690X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypothyroidism associated with parathyroid disorders","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Endocrinology & Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.beem.2017.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}